Huella digital
- 1 Perfiles similares
Colaboraciones y áreas de investigación principales de los últimos cinco años
-
Phase 2 Study of Zilovertamab Vedotin in Participants with Metastatic Solid Tumors
Meric-Bernstam, F., Gutierrez, M., Sanz-Garcia, E., Villa, D., Zhang, J., Friedmann, J., Yan, F., Socinski, M. A., Sarantopoulos, J., Raez, L. E., Chu, Q. S., Chénard-Poirier, M., Chatterjee, M. S., Ren, H., Liu, Q., Levine, D. A. & Jhaveri, K. L., ene 2025, En: Cancer Research Communications. 5, 9, p. 1664-1673 10 p.Producción científica: Article › revisión exhaustiva
Acceso abierto2 El enlace se abre en una pestaña nueva Citas (Scopus) -
Pilot phase II study of the combination of lenvatinib (L) and eribulin (E) in advanced solid tumors
Banwait, R., Ko, H., Michalek, J., Liu, Q., Lathrop, K., Bowhay-Carnes, E., Fotopoulos, G., Sarantopoulos, J., Elledge, R., Taverna, J., Karnad, A., Siziopikou, K. P. & Kaklamani, V., ago 15 2025, En: International Journal of Cancer. 157, 4, p. 752-759 8 p.Producción científica: Article › revisión exhaustiva
Acceso abierto -
A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies
Lin, C. C., Garralda, E., Schöffski, P., Hong, D. S., Siu, L. L., Martin, M., Maur, M., Hui, R., Soo, R. A., Chiu, J., Zhang, T., Ma, B., Kyi, C., Tan, D. S. W., Cassier, P. A., Sarantopoulos, J., Weickhardt, A., Carvajal, R. D., Spratlin, J. & Esaki, T. y 10 otros, , 2024, En: OncoImmunology. 13, 1, 2290787.Producción científica: Article › revisión exhaustiva
Acceso abierto28 El enlace se abre en una pestaña nueva Citas (Scopus) -
Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer
Mahalingam, D., Hanni, S., Serritella, A. V., Fountzilas, C., Michalek, J., Hernandez, B., Sarantopoulos, J., Datta, P., Romero, O., Pillai, S. M. A., Kuhn, J., Pollak, M. & Thompson, I. M., 2023, En: Oncotarget. 14, 1, p. 622-636 15 p.Producción científica: Article › revisión exhaustiva
Acceso abierto7 El enlace se abre en una pestaña nueva Citas (Scopus) -
A First-in-Human, Phase I, Multicenter, Open-Label, Dose-Escalation Study of PCA062: An Antibody-Drug Conjugate Targeting P-Cadherin, in Patients With Solid Tumors
Duca, M., Lim, D. W. T., Subbiah, V., Takahashi, S., Sarantopoulos, J., Varga, A., D'Alessio, J. A., Abrams, T., Sheng, Q., Tan, E. Y., Rosa, M. S., Gonzalez-Maffe, J., Sand-Dejmek, J., Fabre, C. & Martin, M., abr 2022, En: Molecular cancer therapeutics. 21, 4, p. 625-634 10 p.Producción científica: Article › revisión exhaustiva
15 El enlace se abre en una pestaña nueva Citas (Scopus)
Conjuntos de datos
-
Phase 1 study of M2698, a p70S6K/AKT dual inhibitor, in patients with advanced cancer
Tsimberidou, A.-M. (Creator), Shaw, J. V. (Creator), Juric, D. (Creator), Verschraegen, C. (Creator), Weise, A. M. (Creator), Sarantopoulos, J. (Creator), Lopes, G. (Creator), Nemunaitis, J. (Creator), Mita, M. (Creator), Park, H. (Creator), Ellers-Lenz, B. (Creator), Tian, H. (Creator), Xiong, W. (Creator), Kaleta, R. (Creator) & Kurzrock, R. (Creator), Figshare, 2021
DOI: 10.6084/m9.figshare.c.5568537, https://springernature.figshare.com/collections/Phase_1_study_of_M2698_a_p70S6K_AKT_dual_inhibitor_in_patients_with_advanced_cancer/5568537
Dataset
-
Pharmacokinetics of carfilzomib in patients with advanced malignancies and varying degrees of hepatic impairment: an open-label, single-arm, phase 1 study
Brown, J. (Creator), Plummer, R. (Creator), Bauer, T. M. (Creator), Anthony, S. (Creator), Sarantopoulos, J. (Creator), Vos, F. (Creator), White, M. (Creator), Schupp, M. (Creator), Ou, Y. (Creator) & Vaishampayan, U. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3895900.v1, https://figshare.com/collections/Pharmacokinetics_of_carfilzomib_in_patients_with_advanced_malignancies_and_varying_degrees_of_hepatic_impairment_an_open-label_single-arm_phase_1_study/3895900/1
Dataset
-
Phase 1 study of M2698, a p70S6K/AKT dual inhibitor, in patients with advanced cancer
Tsimberidou, A.-M. (Creator), Shaw, J. V. (Creator), Juric, D. (Creator), Verschraegen, C. (Creator), Weise, A. M. (Creator), Sarantopoulos, J. (Creator), Lopes, G. (Creator), Nemunaitis, J. (Creator), Mita, M. (Creator), Park, H. (Creator), Ellers-Lenz, B. (Creator), Tian, H. (Creator), Xiong, W. (Creator), Kaleta, R. (Creator) & Kurzrock, R. (Creator), Figshare, 2021
DOI: 10.6084/m9.figshare.c.5568537.v1, https://springernature.figshare.com/collections/Phase_1_study_of_M2698_a_p70S6K_AKT_dual_inhibitor_in_patients_with_advanced_cancer/5568537/1
Dataset
-
Pharmacokinetics of carfilzomib in patients with advanced malignancies and varying degrees of hepatic impairment: an open-label, single-arm, phase 1 study
Brown, J. (Creator), Plummer, R. (Creator), Bauer, T. M. (Creator), Anthony, S. (Creator), Sarantopoulos, J. (Creator), Vos, F. (Creator), White, M. (Creator), Schupp, M. (Creator), Ou, Y. (Creator) & Vaishampayan, U. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3895900, https://figshare.com/collections/Pharmacokinetics_of_carfilzomib_in_patients_with_advanced_malignancies_and_varying_degrees_of_hepatic_impairment_an_open-label_single-arm_phase_1_study/3895900
Dataset